The Alliance for Clinical Trials in Oncology (Alliance) today announced that the U.S. Food and Drug Administration has ...

New long‑term results from the RUBY clinical trial show that adding immunotherapy (dostarlimab) to chemotherapy may help some ...

A SIX-IN-ONE British-made drug can treat multiple common cancers by blocking tumour cells from hiding from the immune system.

A large clinical trial in China (HARMONi-6) found that a new immunotherapy drug, ivonescimab, may help patients with advanced ...

New findings from a clinical trial highlight the potential for neoadjuvant immunotherapy to eliminate the need for surgery in patients with a particular type of cancer, helping them maintain a higher ...

From infections and allergies to brain diseases and autoimmune disorders, a wave of trials offers hope ...

Add Yahoo as a preferred source to see more of our stories on Google. A new study in the New England Journal of Medicine suggests that some people with early stage cancers may be able to skip surgery ...

Melanoma is the most aggressive form of skin cancer and can be difficult to treat in advanced stages. In a new doctoral ...

GLP-1 RA use was also tied to lower rates of immune-related side effects, caused by the immune system becoming overactive as a result of immunotherapy treatment. Patients taking GLP-1 drugs showed ...

A wonder drug that stops cancer hiding from the immune system can shrink tumours in patients with six common types of the ...

Four years after Teddi Mellencamp was diagnosed with cancer, she shared insight into her day-to-day journey with ...

A new study published in the Journal of Biological Chemistry from UC Davis Comprehensive Cancer Center finds that TIGIT, an immune checkpoint receptor targeted by cancer immunotherapy drugs, triggers ...